Related Experiment Video
Updated: Jul 15, 2026

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
Published on: November 4, 2010
Persistent Airflow Limitation in Asthma: Clinical Characteristics, Risk Factors, and Long-term Outcomes from a
Jung-Kyu Lee1, Hyun-Woo Lee1, Chang Hoon Lee2
1Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Seoul Metropolitan Government-Seoul National University Boramae Medical Center, Seoul National University College of Medicine, Seoul, Republic of Korea.
Background:
Persistent airflow limitation (PAL) is an increasingly recognized asthma phenotype, but its prevalence, determinants, and prognostic significance in real-world settings remain unclear. This study evaluated the clinical characteristics and long-term outcomes associated with PAL and its severity in asthma.
Methods:
Multicenter analysis of combined retrospective and prospective cohorts in South Korea. PAL was defined as post-bronchodilator FEV1/FVC <0.70; severity was graded by STaging of Airflow obstruction by Ratio classification (STAR stage). Outcomes included subsequent exacerbations and longitudinal lung function change.
Results:
Among 849 patients with asthma, 640 (75.4%) had PAL. PAL was associated with older age, male sex, lower body mass index, higher smoking intensity, lower FEV1, history of tuberculosis, and less frequent allergic rhinitis. Optimal predictors of PAL were FEV1 ≤83.7% predicted, age ≥63.5 years, and smoking intensity ≥9.5 pack-years. During follow-up, severe exacerbations occurred more frequently in the PAL group (13.0% vs 5.7%) with a 1.8-fold higher incidence (IRR 1.77, 95% CI 1.13-2.79). Risk increased with PAL severity, particularly at STAR stage 4 vs stage 0 (aHR 3.32, 95% CI 1.60-6.89). Longitudinally, annual FEV1 decline was slower in PAL than in non-PAL (-28.1 vs -42.5 mL/year, P = 0.028), but within PAL, STAR stage 4 showed relatively faster declines in both FEV1 and FVC.
Conclusion:
PAL and its severity independently predict the risk of severe exacerbations and progressive lung function decline in asthma, underscoring PAL as a key marker of disease progression and a potential target for early intervention.
Related Concept Videos
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Asthma III: Clinical Manifestations
Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations
Chronic Obstructive Pulmonary Disease I: Introduction
Asthma-II: Pathophysiology and Classification
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Asthma-III: Symptoms and Complications
Classification of Asthma